Research into a new drug that primes the immune system in the respiratory tract and is in development for COVID-19 shows it is also effective against rhinovirus.

Rhinovirus is the most common respiratory virus, the main cause of the common cold and is responsible for exacerbations of chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease. In a study recently published in the European Respiratory Journal, the drug, known as INNA-X, is shown to be effective in a pre-clinical infection model and in human airway cells.

Treatment with INNA-X prior to infection with rhinovirus significantly reduced viral load and inhibited harmful inflammation.

When will the pandemic end? It’s the question hanging over just about everything since COVID-19 took over the world last year. The answer can be measured in vaccinations.

Bloomberg has built the biggest database of COVID-19 shots given around the world, with more than 108 million doses administered worldwide. U.S. science officials such as Anthony Fauci have suggested it will take 70% to 85% coverage of the population for things to return to normal. Bloomberg’s Vaccine Tracker shows that some countries are making far more rapid progress than others, using 75% coverage with a two-dose vaccine as a target.

Scientists say the EpiMap resource has uncovered “circuitry of the human genome.”

RNA is the central tenet of molecular biology, the stepping-stone between DNA and proteins.

Three different studies, done by different teams of scientists proved something really extraordinary. But when a new research connected these 3 discoveries, something shocking was realized, something hiding in plain sight. Human emotion literally shapes the world around us. Not just our perception of the world, but reality itself.

In the first experiment, human DNA, isolated in a sealed container, was placed near a test subject. Scientists gave the donor emotional stimulus and fascinatingly enough, the emotions affected their DNA in the other room.

Introducing viscoelasticity by addition of DNA into the fluid surrounding a suspension of Escherichia coli produces a giant oscillating vortex with a period controllable through the DNA concentration.

NEW YORK (AP) — Almost six months after a rare face and hands transplant, Joe DiMeo is relearning how to smile, blink, pinch and squeeze.

The 22-year-old New Jersey resident had the operation last August, two years after being badly burned in a car crash.

“I knew it would be baby steps all the way,” DiMeo told The Associated Press. “You’ve got to have a lot of motivation, a lot of patience. And you’ve got to stay strong through everything.”